Some stay; some go: contentious requirements in US guidance on home use devices
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has finalized its guidance on the factors that medical device makers should consider when designing and developing products to be used by patients at homes1,2. While the guidance document contains some of the provisions that the medtech industry had objected to during consultation, other contentious issues have been deleted.